Haggen lines up buyers for 10 stores in Tri-Counties
Latest news, Top StoriesHaggen is looking to sell some of its soon-to-be vacant stores in the Tri-Counties to Gelson’s Markets and Smart & Final pending bankruptcy court approval, the company announced Oct. 5. Gelson’s and Smart & Final got the first pick of 127 shuttering Haggen stores. The high-end Encino-based grocer Gelson’s signed an asset purchase agreement Read More →
Cal Amp’s second quarter earnings beat analyst estimates
Earnings, Latest news, Tri-County Public CompaniesOxnard-based Cal Amp, which makes products for the wireless sector, beat analyst estimates on Oct. 1 when it reported second quarter 2016 results. Cal Amp posted earnings of 27 cents per share, beating analyst estimates of 26 cents per share. Analysts expected Cal Amp’s revenues to be around $68 million, but the company beat those Read More →
Goodland Hotel in Goleta sold for $41 million
Latest news, Real Estate, TourismThe Goodland Hotel in Goleta was sold to KHP Capital Partners for $40.9 million in September, property records show. The 158-room lodge was developed by Makar Properties, a privately owned real estate development company based in Newport Beach. Makar acquired the former Holiday Inn in June 2013 for $24 million and opened as The Goodland in Read More →
Firestone Walker wins ‘Brewer of the Year’ trophy, again
Latest newsFirestone Walker has moved a step closer to retiring the “Brewer of the Year” trophy for mid-sized companies in the craft beer segment. The Paso Robles-based maker of popular brands such as “805” took home “Mid-Sized Brewing Company and Brewer of the Year” honors for the fourth time in less than a decade at the Read More →
European regulators have good news for Amgen on cancer drugs
Health Care & Life Science, Latest news, Technology, Tri-County Public CompaniesOne of the world’s most expensive cancer drugs got conditional approval from European regulators on Sept. 25. Europeans granted Thousand Oaks-based Amgen conditional approval of its rare blood cancer drug Blincyto and gave a positive evaluation of Amgen’s multiple-myeloma drug Kyprolis. Blincyto is an immunotherapy that is designed to treat a rare form of leukemia Read More →
